A Prospective Phase I/II Trial to Jointly Optimize the Administration Schedule and Dose of Melphalan for Injection (Evomela) As a Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma
Year: 2021
Type: conference-abstract
Source: Blood
Authors: Qaiser Bashir, Peter F. Thall, Dawen Sui, Jeremy L. Ramdial, Samer A. Srour, Rohtesh S. Mehta, Uday R. Popat, Yago Nieto, Neeraj Saini, Partow Kebriaei, Elisabet E. Manasanch, Hans C. Lee, Gregory P. Kaufman, Sheeba K Thomas, Krina K. Patel, Robert Z. Orlowski, Cristina G. Knape, Jitesh D. Kawedia, Richard E. Champlin, Elizabeth J. Shpall, Xiaoqian Liu, Muzaffar H. Qazilbash
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4200619239